Search Results - "Killick, Emma"

Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status.

Authors: Killick, Emma Tymrakiewicz, Malgorzata Cieza-Borrella, Clara et al.

Source: PLoS ONE. Jan2014, Vol. 9 Issue 1, p1-6. 6p.

Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.

Authors: Killick, Emma Morgan, Richard Launchbury, Francesca et al.

Source: Scientific Reports. 6/28/2013, p1-5. 5p.

Editorial.

Authors: Massey‐Chase, Becca Frost, Stephen Emden, Joshua et al.

Source: IPPR Progressive Review. Dec2024, Vol. 31 Issue 3, p170-173. 4p.

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.

Authors: Saya S Killick E Thomas S et al.

Corporate Authors: Saya S Killick E Thomas S et al.

Source: Familial cancer [Fam Cancer] 2017 Jul; Vol. 16 (3), pp. 433-440.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

Authors: McBride KA Ballinger ML Schlub TE et al.

Source: Familial cancer [Fam Cancer] 2017 Jul; Vol. 16 (3), pp. 423-432.

Publication Type: Clinical Trial; Journal Article

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.

Authors: Bancroft EK Page EC Castro E et al.

Corporate Authors: Bancroft EK Page EC Castro E et al.

Source: European urology [Eur Urol] 2014 Sep; Vol. 66 (3), pp. 489-99. Date of Electronic Publication: 2014 Jan 15.

Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Li-Fraumeni syndrome: cancer risk assessment and clinical management.

Authors: McBride KA Ballinger ML Killick E et al.

Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2014 May; Vol. 11 (5), pp. 260-71. Date of Electronic Publication: 2014 Mar 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins.

Authors: Biswas S Killick E Jochemsen AG et al.

Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2014 May; Vol. 23 (5), pp. 629-45. Date of Electronic Publication: 2014 Feb 28.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE